Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Cii Tech Secures Tens of Millions in Pre-Series A Funding for Mass Spectrometry

January 24, 2025
CompanyDeals

TechnoDerma Raises Series A+ Funding to Advance Dermatology Pipeline

January 24, 2025
CompanyDrug

Konruns’ KC1036 Advances to Phase II Study for Lung Adenocarcinoma

January 24, 2025
CompanyDrug

Harbour BioMed’s HBM1020 Receives FDA Approval for US Phase I Study

January 24, 2025
Company

Porton Pharma Solutions to Invest EUR 50 Million in Slovenia Bio-Industry Park

January 24, 2025
CompanyDigital

ClouDr Partners with Shaanxi Pharmaceutical Firms for Integrated Healthcare Solutions

January 24, 2025
CompanyDeals

Syneos Health Partners with Fosun Pharma to Commercialize Serplulimab in US

January 24, 2025
CompanyDrug

Sanofi’s iGlarLixi Approved in China for Type 2 Diabetes Management

January 24, 2025
CompanyDrug

Roche’s Polivy Approved by China’s NMPA for Lymphoma Treatment

January 25, 2025
Policy / Regulatory

China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs

January 25, 2025
Company

Med Vision Secures A+ Round Financing to Accelerate Digital Therapy Commercialization

November 17, 2024
CompanyDrug

MSD China to Take Legal Action Against Market Infringement of Molnupiravir

January 25, 2025
1 2 … 8 9 10 11 12 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up